Active Genetics & Molecular Biology Cells, Biochemistry & Physiology

ADP-ribosylation signalling in genome stability

In plain English

AI plain-English summary

Every time a cell’s DNA gets damaged—from sunlight, chemicals, or normal copying errors—a molecular tag called ADP-ribose gets slapped onto specific proteins to coordinate the repair. This project deciphers exactly how two newly discovered forms of that tag, attached to the amino acids serine and tyrosine, are added and removed by a set of enzymes (PARP/HPF1, ARH3, and PARG). Without this tagging system, cells accumulate broken DNA, which drives cancer and accelerates ageing. The problem is that the molecular machinery behind these particular tags remains poorly understood. The researchers will use biochemical and structural methods to map the precise mechanisms of tag synthesis and removal, then test which cellular processes—such as DNA repair, chromosome segregation, or cell division—depend on these specific tags, using cell biology and animal models. This is fundamental science: it will not produce a drug or diagnostic tomorrow. But because PARP inhibitors are already used to treat certain cancers, understanding the basic chemistry of ADP-ribosylation could eventually reveal new targets for therapies that prevent genome instability or improve the selectivity of existing treatments.

View original technical description
ADP-ribosylation (ADPr) is a post-translational modification (PTM) of proteins, synthesised by the poly(ADP-ribose) polymerase (PARP) family of enzymes. Through the modification of a variety of mediator/effector proteins, PARPs control cellular processes that are critical for genome stability, including DNA repair, regulation of chromatin structure, transcription, apoptosis and mitosis. However, the proteins involved in these pathways and the mechanisms of regulation remain poorly understood. Recently, we identified ADPr on serine residues in proteins (Ser-ADPr) as the major form of DNA damage induced ADPr and decoded the mechanism for the synthesis (by PARP/HPF1 complexes) and removal (by cooperation between ARH3 and PARG hydrolases) of this modification. We also recently identified the Tyr-ADPr as a novel form of ADPr. One goal of this project is to use biochemical and structural approaches to understand the exact molecular mechanism by which HPF1, PARG and ARH3 work in the synthesis/removal of Ser- and Tyr-ADPr. Another goal is to define the physiological processes controlled by Ser- and Tyr-ADPr and to understand how these processes are regulated in cells, using cell biology approaches and animal models.

View the original record at the funder ↗

Researchers

Ivan Ahel (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Serine ADP-ribosylation in genome stability and human disease
Protein poly(ADP-ribosyl)ation in genome stability and human disease.
Molecular mechanisms of cysteine ADP-ribosylation
Understanding the role of ADP-ribosylation in regulating DNA repair
Understanding the role of PARPs in replication-associated DNA damage repair.

Original classification

Discovery Award

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.